Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
Cures for all presents a real focus for the next decade – but companies must be rewarded for their work.
GE and Alderley Park are teaming up in support of SMEs in Northern England.
Jane Osbourn talks about the potential of the UK's cell and gene therapy space.
Don't forget to nominate the industry's most talented for our 2020 Power List!
What if research hospitals could fully develop and process cell and gene therapies themselves?
Here, we speak with Matthew Moorcroft, Vice President of Marketing & Intelligence at Cambrex.
The US opioid crisis has claimed the lives of hundreds of thousands. We examine pharma’s role.
Continuous processing, exporting generics and alleviating drug shortages… what’s new for pharma in business?
A new campaign highlights how far businesses have to go to close the gender pay gap – and pharma is no exception.
Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.